Investigating the role of Foxp transcription factors in immune regulation

Foxp transcription factors in regulatory T cells

NIH-funded research Veterans Admin Palo Alto Health Care Sys · NIH-11252513

This study is looking at how certain proteins, called Foxp1 and Foxp4, affect the growth and job of special immune cells that help keep our immune system in check, and it’s for anyone interested in understanding how these changes might impact autoimmune diseases and organ transplants.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionVeterans Admin Palo Alto Health Care Sys NIH-funded
Lab location1 site (Palo Alto, United States)
Project IDNIH-11252513 on NIH RePORTER

What this research studies

This research focuses on understanding how specific transcription factors, known as Foxp1 and Foxp4, influence the development and function of regulatory T cells (Tregs), which are essential for maintaining immune tolerance. By creating genetically modified mice that lack these factors, researchers aim to observe changes in Treg development and their ability to suppress immune responses. The study employs advanced techniques such as high throughput sequencing to analyze gene regulation and will test the effects of these changes in models of autoimmune diseases and transplantation.

Who could benefit from this research

Good fit: Ideal candidates for this research would include individuals with autoimmune diseases or those undergoing transplantation who may benefit from improved immune regulation.

Not a fit: Patients with non-autoimmune conditions or those not requiring immune modulation may not receive any benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for treating autoimmune diseases and improving transplant outcomes by enhancing the function of regulatory T cells.

How similar studies have performed: Previous research has shown promising results in understanding the role of transcription factors in immune regulation, suggesting that this approach could yield valuable insights.

Where this research is happening

Palo Alto, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Autoimmune Diseasesautoimmune disorderautoimmunity disease
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.